Hereditary Angioedema – Epidemiology – Emerging Markets
Clarivate Epidemiology’s coverage of hereditary angioedema (HAE) comprises epidemiological estimates of key patient populations in 45 countries. We report the prevalence of HAE for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets of the United States, France, Germany, Italy, Spain, the United Kingdom, and Japan and 10 years for the other countries covered in this report.
Clarivate Epidemiology’s HAE forecast will answer the following questions:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of HAE over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
Clarivate Epidemiology forecasts the following patient populations:
- Diagnosed prevalent cases of HAE.
- Diagnosed prevalent cases of HAE type 1.
- Diagnosed prevalent cases of HAE type 2.
- Diagnosed prevalent cases of HAE type 3.
Note: Coverage may vary by country.
Table of contents
- Hereditary Angioedema - Epidemiology - Emerging Markets
- Introduction
- Key Findings
- Prevalence of Hereditary Angioedema per 100,000 People of All Ages in 2021
- Prevalence of Hereditary Angioedema per 100,000 People of All Ages in 2021 and 2031
- Relative Sizes of the Factors Contributing to the Trend in Prevalent Cases of Hereditary Angioedema Over the Next 10 Years
- Relative Sizes of the Factors Contributing to the Trend in Prevalent Cases of Hereditary Angioedema Over the Next 10 Years
- Number of Additional Prevalent Cases of Hereditary Angioedema Incurred Over 2021-2031 in the Countries Under Study
- Number of Additional Prevalent Cases of Hereditary Angioedema Incurred Over 2021-2031 in the Countries Under Study
- Analysis of Diagnosed Prevalent Cases of Hereditary Angioedema in the Countries Under Study in 2021 by Subtype
- Analysis of Diagnosed Prevalent Cases of Hereditary Angioedema in the Countries Under Study in 2021 by Subtype
- Epidemiology Data
- Methods
- Reference Materials
- Introduction
